This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A discussion of BTK inhibitors in Chronic Lymphocytic Leukemia, including zanabrutinib and NX-5948
Ticker(s): BGNE, ABBV, NRIXWho's the expert?
Institution: City of Hope
- Associate Director, Toni Stephenson Lymphoma Center at City of Hope, directs an effort in experimental therapeutics in B-cell malignancies.
- Focuses on blood cancers, including chronic lymphocytic leukemia and many forms of lymphoma.
- His group's preclinical focus is on evaluation of novel targets in the ubiquitin-proteasome system and oncogenic role of CDK9.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
